MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 506.5 SEK -0.88% Market Closed
Market Cap: kr7.6B

EV/S

3.6
Current
2%
More Expensive
vs 3-y average of 3.5

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
3.6
=
Enterprise Value
kr7.2B
/
Revenue
kr2.1B

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
3.6
=
Enterprise Value
kr7.2B
/
Revenue
kr2.1B

Valuation Scenarios

MedCap AB (publ) is trading above its 3-year average

If EV/S returns to its 3-Year Average (3.5), the stock would be worth kr494.51 (2% downside from current price).

Statistics
Positive Scenarios
1/4
Maximum Downside
-41%
Maximum Upside
+10%
Average Downside
9%
Scenario EV/S Value Implied Price Upside/Downside
Current Multiple 3.6 kr506.5
0%
3-Year Average 3.5 kr494.51
-2%
5-Year Average 3.5 kr485.42
-4%
Industry Average 4 kr557.61
+10%
Country Average 2.1 kr298.11
-41%

Forward EV/S
Today’s price vs future revenue

Today's Enterprise Value Revenue Forward EV/S
kr7.2B
/
Jan 2026
kr2.1B
=
3.6
Current
kr7.2B
/
Dec 2026
kr2.4B
=
3
Forward
kr7.2B
/
Dec 2027
kr2.7B
=
2.7
Forward
kr7.2B
/
Dec 2028
kr3B
=
2.4
Forward

Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
EV/S
P/E
All Countries
Close
Market Cap EV/S P/E
SE
MedCap AB (publ)
STO:MCAP
7.6B SEK 3.6 34.6
US
PerkinElmer Inc
LSE:0KHE
1T USD 362.1 4 280.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
175.6B USD 4.5 26.2
US
Danaher Corp
NYSE:DHR
126.2B USD 5.7 34.9
KR
Samsung Biologics Co Ltd
KRX:207940
82.3T KRW 17.9 46.1
CH
Lonza Group AG
SIX:LONN
34.3B CHF 5.7 -122.4
CN
WuXi AppTec Co Ltd
SSE:603259
298.9B CNY 5.8 15.6
US
Agilent Technologies Inc
NYSE:A
32.3B USD 4.8 25.1
US
Waters Corp
NYSE:WAT
30.5B USD 9.8 47.5
US
IQVIA Holdings Inc
NYSE:IQV
27.3B USD 2.4 20.1
US
Mettler-Toledo International Inc
NYSE:MTD
25.7B USD 6.9 29.6

Market Distribution

In line with most companies in Sweden
Percentile
62st
Based on 1 369 companies
62st percentile
3.6
Low
0 — 1.1
Typical Range
1.1 — 5.1
High
5.1 —
Distribution Statistics
Sweden
Min 0
30th Percentile 1.1
Median 2.1
70th Percentile 5.1
Max 15 188

MedCap AB (publ)
Glance View

MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Solna, Stockholm. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

MCAP Intrinsic Value
466.48 SEK
Overvaluation 8%
Intrinsic Value
Price kr506.5
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett